This part of our data demonstrates that, unlike IL-4 induction, a proliferative potential of CLL B cells might be dependent on BTLA protein expression level, thus indicating the involvement of BTLA molecule quantitative defect in promotion of B cell dysfunctional state. The gene discussed is IL4; the disease is B-cell chronic lymphocytic leukemia.